BacMuno
Have updates for this profile? Please contribute data
= Subscriber Access Only
You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.
With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.
BacMuno - overview
Location
Hong Kong, -, Hong Kong SAR - China
Primary Industry
Pharmaceuticals
About
Based in Hong Kong, BacMuno operates as a biopharmaceutical company that develops bacteria-based cancer immunotherapies for humans and animals.
Current Investors
Hong Kong X Technology Fund
Primary Industry
Pharmaceuticals
Sub Industries
Biopharmaceuticals, Epidemiology, Oncology/Cancer Treatment, Pharmaceutical Research & Development
Website
www.bacmuno.hk
Company Stage
Early Stage
Total Amount Raised
Subscriber access only
Time to go Pro
Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.